Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitetiltanpharma.com
CategoryBioTech
Emailinfo@tiltanpharma...
Employees

Offices

Jerusalem, ISR
1-1 Hi-tech Village, Edmond Safra Campus Givat Ram
P.O.B. 39026,
Jerusalem, 91390, ISR

People

Funding

TOTAL $1.5M
FUNDING TOTAL $1.5M
Venture Round, 2/2014
$1.5M

Tags

Tiltan Pharma

One of the major advances in cancer research over the past decade has been the realization that tumor growth is dependent on the tumor’s ability to recruit blood vessels from the neighboring tissue. Angiogenesis, the process by which new blood vessels are formed, is a hallmark capability of cancer, critical for the development of all solid tumors. This property is the basis for anti-angiogenic therapy, a promising novel strategy for treatment of cancer.

Recent Milestones

Videos

Screenshots

Tiltan Pharma screenshot
Above: Homepage
Uploaded: 2/5/14

Sources

  1. Tiltan Pharma Raises $1.5 Million (bioportfolio.com) [edit]
Edit This Page
Last Edited 2/5/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy